Discover 3,133 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,133
Expansion and Evaluation of AI-generated Clinical Assessment (AI-COA®) of Depression and Anxiety Severity
for
Depression Disorders, Anxiety Disorders
Location: Houston TX
Sponsor: Deliberate Solutions Inc.
Sex: All
Age: 18 - 65
Code: NCT06923995
Recruiting
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Houston TX, San Antonio TX, Dallas TX, Little Rock AR,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06297226
Phase 2, Recruiting
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
for
Pulmonary Arterial Hypertension (PAH),
Location: Houston TX, Kansas City KS, Jacksonville FL, Aurora CO,
Sponsor: AllRock Bio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07175038
Phase 2, Recruiting
The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing Myopathy
Location: Houston TX, Birmingham AL, Pittsburgh PA
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 16+
Code: NCT06599697
Phase 2, Recruiting
Coordinating and Data Management Center for the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer
for
Chronic Pancreatitis, Diabetes, Pancreatic Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 0+
Code: NCT03058926
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment
for
Primary Myelofibrosis (PMF),
Location: Houston TX, Nashville TN, Saint Louis MO, Chicago IL,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT03662126
Phase 2, Phase 3, Recruiting
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Location: Houston TX, Dallas TX, Nashville TN, St Louis MO,
Sponsor: Pierre Fabre Medicament
Sex: All
Age: 0+
Code: NCT03394365
Phase 3, Recruiting
Skin-to-skin Care Using the Skincubator: Feasibility and Safety Trial
for
Skin to Skin Care for Preterm Infants
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 0
Code: NCT07721662
Recruiting
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
for
Advanced Solid Tumors, Breast Cancer Recurrent, Ovarian Cancer,
Location: Houston TX, San Antonio TX, Nashville TN, St Louis MO,
Sponsor: Accent Therapeutics
Sex: All
Age: 18+
Code: NCT06799065
Phase 1, Phase 2, Recruiting
Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)
for
Acute Myeloid Leukemia, Myelodysplastic Syndromes
Location: Houston TX
Sponsor: Cyclacel Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT01211457
Phase 1, Phase 2, Recruiting
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
for
T-cell NHL (PTCL or CTCL)
Location: Houston TX, St Louis MO, New York NY, Stanford CA
Sponsor: Kyowa Kirin, Inc.
Sex: All
Age: 18+
Code: NCT07192471
Phase 1, Recruiting
Augmented Reality-Cardiopulmonary Resuscitation Support for Pediatric Resuscitation